Post-IPO Equity Medical Companies

Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.

Veru is a biopharmaceutical company that specializes in developing novel medicines.

Biora Therapeutics is the biotech company.

Cognetivity Neurosciences is a Platform technology for early, rapid and easy detection of dementia.

G Medical Innovations is a next-generation mobile health (mHealth) and e-health company.

Aurora is an early-stage start-up company focused on bringing advanced solutions to the spinal implant market.

Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.

TempraMed provides last-mile control and management solutions to protect patients from temperature-sensitive medications.

Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.

Grail is a healthcare company that develops pan-cancer screening tests designed to detect cancers at an early stage.

Dice Therapeutics is a clinical-stage biopharmaceutical company that makes medicines for chronic autoimmune and inflammatory diseases.

C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.

Adagio Medical is engaged in the research and development of treatments for cardiovascular diseases.

ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.

VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.

NeurAxis develops neuromodulation therapies to address chronic and debilitating conditions in children.

Quoin Pharmaceuticals is into developing products which address major unmet medical needs.